Open AccessS0787 An Update on the Analysis of Non-Melanoma Skin Cancer in the Tofacitinib Ulcerative Colitis Clinical Program as of May 2019
Author(s) -
Bruce E. Sands,
Walter Reinisch,
Julián Panés,
Paulo Gustavo Kotze,
D Judd,
Rajiv Mundayat,
Nervin Lawendy
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000705196.89572.d4
Subject(s) - tofacitinib , medicine , skin cancer , ulcerative colitis , janus kinase inhibitor , cohort , adverse effect , gastroenterology , dermatology , oncology , surgery , cancer , rheumatoid arthritis , disease